Ethosuximide
- Product NDC
- 61748-025
- 11-digit product format
- 617480025
- Labeler code
- 61748
- Product ID
- 61748-025_61032dd5-2391-4dd0-9899-7909e2ea4e1a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Ethosuximide
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Akorn
- Application
- ANDA040686
- Marketing category
- ANDA
- Marketing start
- 2008-09-01
- Marketing end
- 0000-00-00
- Substance
- ETHOSUXIMIDE
- Active strength
- 250 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| dcc989c7-4ccb-d599-44b3-233abc5285bb | Product name | 3 | 20200708 |
| 6084a4f4-5437-c9a5-caec-5361ee075a59 | Product name | 1 | 20140508 |
| 90c5639a-61b0-88d6-ddcf-21888e94869a | Product name | 1 | 20140508 |
| 9514609b-a2a9-f8ec-6ba6-3f8e5ee89877 | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 61748-025-01 | 2024-01-30 | C162847 | 48780-1 | 1030e364-fe73-111a-e063-dadaa90a10e2 | Ethosuximide Capsules, USP |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 61748-025-01 | Ethosuximide | 100 in 1 BOTTLE | CAPSULE | 100 | 7 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 61748-025-01 | EA - Each | 61748-025 | e9827fe9-9b72-4366-8e1a-de2802742b8b | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| ETHOSUXIMIDE | ACTIVE INGREDIENT | 5SEH9X1D1D | ETHOSUXIMIDE CAPSULE [VERSAPHARM INCORPORATED] | 3 | |
| ETHOSUXIMIDE | ACTIVE MOIETY | 5SEH9X1D1D | ETHOSUXIMIDE CAPSULE [VERSAPHARM INCORPORATED] | 3 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | ETHOSUXIMIDE CAPSULE [VERSAPHARM INCORPORATED] | 3 | |
| FD&C YELLOW NO. 6 | INACTIVE INGREDIENT | H77VEI93A8 | ETHOSUXIMIDE CAPSULE [VERSAPHARM INCORPORATED] | 3 | |
| GELATIN | INACTIVE INGREDIENT | 2G86QN327L | ETHOSUXIMIDE CAPSULE [VERSAPHARM INCORPORATED] | 3 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | ETHOSUXIMIDE CAPSULE [VERSAPHARM INCORPORATED] | 3 | |
| POLYETHYLENE GLYCOL 400 | INACTIVE INGREDIENT | B697894SGQ | ETHOSUXIMIDE CAPSULE [VERSAPHARM INCORPORATED] | 3 | |
| SORBITOL | INACTIVE INGREDIENT | 506T60A25R | ETHOSUXIMIDE CAPSULE [VERSAPHARM INCORPORATED] | 3 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 197682 | ethosuximide 250 MG Oral Capsule | PSN | 01e8e8ee-b19f-4b3f-a140-9c7391393e1c | 7 |
| 197682 | ethosuximide 250 MG Oral Capsule | SCD | 01e8e8ee-b19f-4b3f-a140-9c7391393e1c | 7 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 61748-025-01 | 61748002501 | 100 CAPSULE in 1 BOTTLE (61748-025-01) | 100 capsule | 2008-09-01 | 0000-00-00 | No | No | Current |